Regulatory system of mGluR group II in the nucleus accumbens for methamphetamine-induced dopamine increase by the medial prefrontal cortex

Neuropsychopharmacol Rep. 2019 Sep;39(3):209-216. doi: 10.1002/npr2.12068. Epub 2019 Jul 8.

Abstract

Aim: We previously reported that methamphetamine (METH)-induced conditioned place preference was attenuated by Shati/Nat8l overexpression in the medial prefrontal cortex (mPFC). Shati/Nat8l overexpression in the mPFC expressed lower levels of both glutamate and dopamine (DA) in the nucleus accumbens (NAc) and attenuated METH-induced DA elevation. We suggested a mechanism in which a decline of glutamate levels in the NAc decreases extracellular DA levels. However, the hypothesis has not confirmed.

Methods: We conducted a recovery experiments by pre-microinjection of an mGluR group II antagonist, LY341495, into the NAc shell of mPFC-Shati/Nat8l-overexpressed mice followed by METH injection and DA levels measurement by in vivo microdialysis.

Results: Pretreatment with LY341495 was able to restore METH-induced DA increase. Furthermore, mice injected with an adeno-associated virus vector containing GFP (AAV-GFP vector) in the mPFC expressed a colocalization of GFP with DARPP-32 a medium spiny neuron (MSN) marker. Next, co-immunostaining of DARPP-32 and neuronal nitric oxide synthase (nNOS: expressed in a subtype of gamma-Aminobutyric acid (GABA interneurons) in ventral tegmental area (VTA) showed a colocalization of nNOS and DARPP-32.

Conclusion: These results provided a proof that Shati/Nat8l attenuation of METH-induced DA increase is mediated by mGluR group II in the NAc. Moreover, immunohistochemical study showed a direct connection of mPFC projection neurons with NAc MSN and a connection of MSN projection neurons with a subtype of GABA interneurons in VTA.

Keywords: NAc; Shati/Nat8l; VTA; mGluR group II; mPFC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetyltransferases / metabolism
  • Amino Acids / pharmacology
  • Animals
  • Dopamine / metabolism*
  • Dopamine Agents / pharmacology*
  • Dopamine and cAMP-Regulated Phosphoprotein 32 / genetics
  • Dopamine and cAMP-Regulated Phosphoprotein 32 / metabolism
  • Excitatory Amino Acid Antagonists / pharmacology
  • Glutamic Acid / metabolism
  • Male
  • Methamphetamine / pharmacology*
  • Mice
  • Mice, Inbred C57BL
  • Nucleus Accumbens / drug effects
  • Nucleus Accumbens / metabolism*
  • Prefrontal Cortex / drug effects
  • Prefrontal Cortex / metabolism*
  • Receptors, Metabotropic Glutamate / metabolism*
  • Xanthenes / pharmacology

Substances

  • Amino Acids
  • Dopamine Agents
  • Dopamine and cAMP-Regulated Phosphoprotein 32
  • Excitatory Amino Acid Antagonists
  • LY 341495
  • Ppp1r1b protein, mouse
  • Receptors, Metabotropic Glutamate
  • Xanthenes
  • Glutamic Acid
  • Methamphetamine
  • Acetyltransferases
  • Shati protein, mouse
  • Dopamine